21 – 22 May 2020| London, UK
With excitement focused on translating understanding of immune system into patient benefit, the congress considers the best approaches to develop innovative, lasting cures for autoimmune disorders.
Over 150 autoimmunity, immunology and inflammation attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic and healthcare institutions.
Over 20 presentations and case studies focussed on the development of innovative therapies for autoimmune disorders.
View Agenda: http://bit.ly/2Rk74cS
PLUS interactive opportunities including:
2 roundtable discussions on the key industry growth areas within autoimmunity
Panel discussion on the best strategies to translate a proof of concept into the clinic
Go Social: Join our Advances in Immunotherapy Group on LinkedIn, follow us on Twitter @ImmunoOncConf and join the congress conversation on #IMMUNOUK20
For more information about the event, please contact Danielle Dalby at d.dalby@oxfordglobal.co.uk or the Website: http://bit.ly/36jHTes